|
|
Colorectal cancer and Lynch syndrome
Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists.
PPAR research
Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker.
Cancer gene therapy
Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer.
Cancer immunology, immunotherapy : CII
Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma.
European urology
Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma.
Cancer
Prevention of tumor cell reimplantation during transurethral resection: the in-vitro antiadhesive and cytotoxic properties of an irrigant containing polyethylene glycol 400.
Anti-cancer drugs
Bladder cancer: can we move beyond chemotherapy?
Current oncology reports
Autophagy is induced by adenoviral-mediated interferon alpha treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced.
Cancer gene therapy
Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells.
Oncology reports
Immortalized human urothelial cells as a model of arsenic-induced bladder cancer.
Toxicology
Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells.
Anticancer research
Advanced bladder cancer: new agents and new approaches. A review.
Urologic oncology
Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
European urology
Urothelial carcinoma: stem cells on the edge.
Cancer metastasis reviews
Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumors.
Current drug delivery
Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion.
International journal of cancer. Journal international du cancer
Direct gene transfer of adenoviral-mediated interferon α into human bladder cancer cells but not the bystander factors produced induces endoplasmic reticulum stress-related cytotoxicity.
Cancer gene therapy
New molecular targets and novel agents in the treatment of advanced urothelial cancer.
Seminars in oncology
The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.
The Urologic clinics of North America
[The bacillus Calmette-Guérin as immunomodulator in bladder cancer].
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición
PPAR research
Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker.
Cancer gene therapy
Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer.
Cancer immunology, immunotherapy : CII
Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma.
European urology
Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma.
Cancer
Prevention of tumor cell reimplantation during transurethral resection: the in-vitro antiadhesive and cytotoxic properties of an irrigant containing polyethylene glycol 400.
Anti-cancer drugs
Bladder cancer: can we move beyond chemotherapy?
Current oncology reports
Autophagy is induced by adenoviral-mediated interferon alpha treatment in interferon resistant bladder cancer and normal urothelial cells as a cell death protective mechanism but not by the bystander factors produced.
Cancer gene therapy
Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells.
Oncology reports
Immortalized human urothelial cells as a model of arsenic-induced bladder cancer.
Toxicology
Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells.
Anticancer research
Advanced bladder cancer: new agents and new approaches. A review.
Urologic oncology
Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
European urology
Urothelial carcinoma: stem cells on the edge.
Cancer metastasis reviews
Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumors.
Current drug delivery
Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion.
International journal of cancer. Journal international du cancer
Direct gene transfer of adenoviral-mediated interferon α into human bladder cancer cells but not the bystander factors produced induces endoplasmic reticulum stress-related cytotoxicity.
Cancer gene therapy
New molecular targets and novel agents in the treatment of advanced urothelial cancer.
Seminars in oncology
The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.
The Urologic clinics of North America
[The bacillus Calmette-Guérin as immunomodulator in bladder cancer].
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición
Get breaking news about nutritional cures, dangerous chemicals, superfoods and more.
Subscribe to the FREE Natural News email newsletter. Your privacy is protected.
See more studies on Colorectal cancer and...
How is this determined?
The order of these related concepts is determined by a statistical analysis of the scientific literature. Highest-frequency concepts appear first.
|
cancer 8642 Tumor 2243 blood 1139 chemotherapy 1003 colon cancer 907 Death 532 Inflammatory 389 rectum 323 Toxicity 286 Hereditary nonpolyposis colorectal cancer 281 lead 237 breast cancer 195 Chemotherapeutic 171 Familial adenomatous polyposis 168 Alcohol 165 smoking 163 barium 158 Vitamin 145 Gastric cancer 144 radiotherapy 132 aspirin 120 Meat 116 Fat 116 Colitis 112 Chemopreventive 110 Enzymes 105 |
Body Mass Index 100 Calcium 97 diabetes 96 Obesity 91 Ulcerative colitis 90 Lynch syndrome 89 Folate 85 prostate 85 Glucose 74 Vegetables 73 Inflammatory Bowel Disease 72 Insulin 69 NSAIDs 65 Vitamin D 63 red meat 60 prostate cancer 51 overweight 41 fish 37 Diabetes mellitus 34 Exercise 33 Iron 33 coffee 24 Abdominal aortic aneurysm 16 Constipation 16 Glutathione 15 |
